Regeneron Pharmaceuticals (REGN)

Net Change in Cash

-$908.30M

TTM · Period ending: · USD

REGN logo

REGN Net Change in Cash

Latest reported-$908.30M
REGN TTM Net Change in Cash (-$9.80M → -$908.30M)
High-resolution chart · PNG

REGN net change in cash history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Net Change in Cash — Trailing twelve months (TTM) (USD)
Period endingNet Change in Cash (USD)
-908,300,000
-122,400,000
634,700,000
501,300,000
87,400,000
483,200,000
-248,800,000
-148,400,000
-21,500,000
-1,319,000,000
-381,600,000
-1,344,600,000
-1,458,900,000
569,600,000
221,300,000
59,900,000
1,323,900,000
1,908,800,000
690,800,000
1,858,300,000
80,000,000
-770,300,000
577,000,000
189,300,000
946,700,000
499,700,000
150,100,000
296,957,000
127,624,000
689,009,000
654,967,000
295,778,000
173,563,000
207,718,000
277,530,000
-128,294,000
97,805,000
207,559,000
-273,899,000
265,772,000
255,954,000
96,307,000
160,383,000
8,033,000
-209,581,000
46,049,000
113,111,000
383,343,000
218,460,000
281,496,000
305,332,000
144,213,000
209,732,000
-214,223,000
-253,334,000
-87,397,000
-82,369,000
259,209,000
371,038,000
-118,891,000
142,312,000
18,065,000
-94,503,000
74,965,000
-159,466,000
-81,786,000
-40,721,000
-64,363,000
-20,663,000
-321,778,000
-251,129,000
217,268,000
182,486,000
364,391,000
261,049,000
-70,246,000
-5,317,000
-25,848,000
53,368,000
-8,431,000
-30,241,000
34,516,000
89,279,000
77,051,000
28,373,000
-20,213,000
-17,051,000
-193,570,000
-6,826,000
-17,552,000
38,208,000
223,043,000
60,285,000
56,117,000
-167,316,000
-24,400,000
-73,581,000
-48,151,000
216,415,000
50,333,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.